Grace Therapeutics, Inc. financial data

Symbol
GRCE on Nasdaq
Location
103 Carnegie Center, Suite 300, Princeton, NJ
Fiscal year end
March 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 971 % -2.98%
Debt-to-equity 9.99 % -43.3%
Return On Equity -12.8 % +33.5%
Return On Assets -11.6 % +28.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.5M shares +52.6%
Common Stock, Shares, Outstanding 14.1M shares
Entity Public Float 24M USD +36.5%
Common Stock, Value, Issued 258M USD +0.04%
Weighted Average Number of Shares Outstanding, Basic 15.9M shares +38.4%
Weighted Average Number of Shares Outstanding, Diluted 15.9M shares +38.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.35M USD -39.3%
Selling and Marketing Expense 252K USD -61.9%
General and Administrative Expense 7.15M USD -1.84%
Operating Income (Loss) -12.5M USD +22.3%
Nonoperating Income (Expense) 3.06M USD +68.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.44M USD +33.9%
Income Tax Expense (Benefit) -1.62M USD +39.3%
Net Income (Loss) Attributable to Parent -7.82M USD +32.6%
Earnings Per Share, Basic 0 USD/shares +43.5%
Earnings Per Share, Diluted 0 USD/shares +43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.9M USD +11.3%
Accounts Receivable, after Allowance for Credit Loss, Current 398K USD -52.4%
Assets, Current 17.3M USD +7.7%
Property, Plant and Equipment, Net 15K USD -37.5%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 41.1M USD 0%
Goodwill 8.14M USD 0%
Assets 66.6M USD +1.88%
Employee-related Liabilities, Current 412K USD +10.5%
Accrued Liabilities, Current 814K USD -18.1%
Liabilities, Current 1.25M USD -53.4%
Deferred Income Tax Liabilities, Net 2.31M USD -41.3%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 3.76M USD -59.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.04M USD 0%
Retained Earnings (Accumulated Deficit) -225M USD -3.6%
Stockholders' Equity Attributable to Parent 62.8M USD +11.9%
Liabilities and Equity 66.6M USD +1.88%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.8M USD +49.9%
Net Cash Provided by (Used in) Financing Activities -327K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares
Common Stock, Shares, Issued 14.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.13M USD +41.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.9M USD +11.3%
Deferred Tax Assets, Valuation Allowance 49.5M USD +4.75%
Deferred Tax Assets, Gross 58.8M USD +10.6%
Operating Lease, Liability 0 USD -100%
Depreciation 2K USD +100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.82M USD +32.6%
Lessee, Operating Lease, Liability, to be Paid 24K USD
Property, Plant and Equipment, Gross 26K USD -96.4%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 105K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 24K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 108K USD
Deferred Tax Assets, Operating Loss Carryforwards 43M USD +5.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 112K USD
Additional Paid in Capital 294M USD +1506%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.25M USD +58%
Share-based Payment Arrangement, Expense 326 USD -26.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares